Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.3B | 11.8B | 3.6B | 4.8B |
Cost of revenue | 3.4B | 13.5B | 2.7B | 1.7B |
Gross profit | 866M | -1.7B | 861M | 3.1B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 76M | -2.2B | 62M | 1.6B |
Operating income | 790M | 517M | 799M | 883M |
Non operating interest income | ||||
Income | 72M | 137M | 45M | -10M |
Expense | 33M | 14M | 31M | 2M |
Other income expense | — | — | — | — |
Pretax income | 824M | 374M | 793M | 781M |
Tax provision | 227M | -44M | 224M | 256M |
Net income | 597M | 418M | 569M | 525M |
Basic EPS | 0.5 | — | 0.4 | — |
Diluted EPS | 0.5 | — | 0.4 | — |
Basic average shares | 1.3B | — | 1.3B | — |
Diluted average shares | 1.3B | — | 1.3B | — |
EBITDA | 1.1B | 934M | 1.1B | 1.1B |
Net income from continuing op. | 597M | 1.1B | 569M | 525M |
Minority interests | -5M | -5M | -4M | -7M |
Preferred stock dividends | 0 | 0 | 0 | 0 |